SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001599298-23-000048
Filing Date
2023-05-03
Accepted
2023-05-03 16:30:04
Documents
17
Period of Report
2023-05-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K smmt-20230503.htm   iXBRL 8-K 38848
2 EX-99.1 a2023_prx0502xannounceme.htm EX-99 12028
7 a2023_prx0502xannounceme001.jpg GRAPHIC 224576
8 a2023_prx0502xannounceme002.jpg GRAPHIC 243811
9 a2023_prx0502xannounceme003.jpg GRAPHIC 232269
  Complete submission text file 0001599298-23-000048.txt   1191212

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20230503.xsd EX-101.SCH 2159
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20230503_def.xml EX-101.DEF 15283
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20230503_lab.xml EX-101.LAB 29621
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20230503_pre.xml EX-101.PRE 15940
11 EXTRACTED XBRL INSTANCE DOCUMENT smmt-20230503_htm.xml XML 11117
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36866 | Film No.: 23884505
SIC: 2834 Pharmaceutical Preparations